Cholinesterase inhibitors may, in addition to improving ratings of cognitive functions, global assessments and activities of daily living, also be beneficial for alleviating many of the characterizing and burdensome NPS in LBD [57–59], which may explain the relatively minor difference compared to AD. Here, BCHE is linked to Alzheimer disease.